AJP - Heart Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 289: H1506-H1511, 2005. First published May 13, 2005; doi:10.1152/ajpheart.00182.2005
0363-6135/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/4/H1506    most recent
00182.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Danzi, S.
Right arrow Articles by Klein, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Danzi, S.
Right arrow Articles by Klein, I.

Effect of serum triiodothyronine on regulation of cardiac gene expression: role of histone acetylation

Sara Danzi,1 Peter Dubon,1 and Irwin Klein1,2

1Department of Medicine and Institute for Medical Research, North Shore University Hospital, Manhasset; and 2Department of Cell Biology, New York University School of Medicine, New York, New York

Submitted 23 February 2005 ; accepted in final form 9 May 2005

Thyroid hormone regulates the transcription of several important cardiac genes. Although the thyroid gland produces predominantly thyroxine (T4), it is triiodothyronine (T3) that is transported across the sarcolemma and binds to nuclear thyroid hormone receptor proteins; yet various studies suggest that serum T3 levels do not accurately reflect cellular T3 action. To address this question, we studied the dose-response relationship of T3 administered by constant infusion in hypothyroid animals with the simultaneous in vivo transcription rate of the cardiac-specific {alpha}-myosin heavy chain (MHC) gene, measured by quantitating {alpha}-MHC heteronuclear (hn)RNA content. Constant infusion of 4 µg T3·kg body wt–1·day–1 for 3 days normalized serum T3 and restored transcription to euthyroid levels; in contrast, daily injections of the same dose increased {alpha}-MHC transcription by only 55% of that obtained by infusion. Although infusion of T3 at 1.25 µg T3·kg body wt–1·day–1 was not sufficient to restore serum T3 to normal, it was capable of restoring transcription to normal at 3 days, but when administered for 12 days, transcription of {alpha}-MHC was found to be 50% of euthyroid levels, demonstrating a decreased sensitivity to T3 over time. Treatment with trichostatin A (TSA) to inhibit histone deacetylation increased levels of total nuclear acetylated histone H4 by almost 50% but was without effect on the real-time PCR measures of {alpha}-MHC hnRNA. TSA administered together with T3 (10 µg T3/kg body wt) significantly increased transcription of {alpha}-MHC after 30 h, thus demonstrating a potential role for histones as cofactors in the T3 regulation of cardiac {alpha}-MHC transcription.

heteronuclear RNA; thyroid hormone; transcription; trichostatin A



Address for reprint requests and other correspondence: I. Klein, North Shore University Hospital, 350 Community Drive, Manhasset, NY 11030 (e-mail: iklein{at}nshs.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.